中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 39 Issue 12
Dec.  2023
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2023  >  39(12): 2970-2977

Changes in intestinal microbiota and application of probiotics in patients with acute pancreatitis

DOI: 10.3969/j.issn.1001-5256.2023.12.033

  • Department of Hepatobiliary and Pancreatic Medicine，The First Hospital of Jilin University，Changchun 130021，China

Research funding:

Research on Population and Health Development of Jilin City (371170143428)

More Information
  • Corresponding author: JI Huifan， Jihf@jlu.edu.cn （ORCID： 0000-0001-8816-1906）
  • Received Date: 2023-03-27
  • Accepted Date: 2023-05-05
  • Published Date: 2023-12-12
    Abstract
  • Intestinal microbiota is the most complex and important microecosystem in the human body， and gut microbiota dysbiosis is closely associated with the development and progression of acute pancreatitis. Targeted regulation of intestinal microecology in assisting the treatment of acute pancreatitis has attracted more attention in recent years. This article describes the changes in intestinal microbiota and related mechanisms in patients with acute pancreatitis， summarizes the current research status of the use of probiotics， points out the research direction of probiotics as the adjuvant treatment regime， and proposes a new method for predicting the dominant flora in patients with acute pancreatitis， in order to bring new ideas for the treatment of acute pancreatitis.

     

    • FullText(HTML)
  • loading
    • References(60)
  • [1]
    de-MADARIA E, CAPURSO G. COVID-19 and acute pancreatitis: Examining the causality[J]. Nat Rev Gastroenterol Hepatol, 2021, 18( 1): 3- 4. DOI: 10.1038/s41575-020-00389-y.
    [2]
    XIAO AY, TAN MLY, WU LM, et al. Global incidence and mortality of pancreatic diseases: A systematic review, meta-analysis, and meta-regression of population-based cohort studies[J]. Lancet Gastroenterol Hepatol, 2016, 1( 1): 45- 55. DOI: 10.1016/S2468-1253(16)30004-8.
    [3]
    BANKS PA, BOLLEN TL, DERVENIS C, et al. Classification of acute pancreatitis: 2012: Revision of the Atlanta classification and definitions by international consensus[J]. Gut, 2013, 62( 1): 102- 111. DOI: 10.1136/gutjnl-2012-302779.
    [4]
    PATEL BK, PATEL KH, BHATIA M, et al. Gut microbiome in acute pancreatitis: A review based on current literature[J]. World J Gastroenterol, 2021, 27( 30): 5019- 5036. DOI: 10.3748/wjg.v27.i30.5019.
    [5]
    CEN ME, WANG F, SU Y, et al. Gastrointestinal microecology: A crucial and potential target in acute pancreatitis[J]. Apoptosis, 2018, 23( 7-8): 377- 387. DOI: 10.1007/s10495-018-1464-9.
    [6]
    MARCHESI JR, RAVEL J. The vocabulary of microbiome research: A proposal[J]. Microbiome, 2015, 3: 31. DOI: 10.1186/s40168-015-0094-5.
    [7]
    QIN JJ, LI RQ, RAES J, et al. A human gut microbial gene catalogue established by metagenomic sequencing[J]. Nature, 2010, 464( 7285): 59- 65. DOI: 10.1038/nature08821.
    [8]
    TIAN XM, WANG H, LIANG JX, et al. Distribution characteristics of intestinal flora among healthy young adults[J]. Cent South Pharm, 2021, 19( 11): 2291- 2299. DOI: 10.7539/j.issn.1672-2981.2021.11.009.

    田学梅, 王慧, 梁静宣, 等. 健康青年人肠道菌群的分布特征研究[J]. 中南药学, 2021, 19( 11): 2291- 2299. DOI: 10.7539/j.issn.1672-2981.2021.11.009.
    [9]
    ZHU Y, HE C, LI XY, et al. Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice[J]. J Gastroenterol, 2019, 54( 4): 347- 358. DOI: 10.1007/s00535-018-1529-0.
    [10]
    CHEN J, HUANG CL, WANG JJ, et al. Dysbiosis of intestinal microbiota and decrease in paneth cell antimicrobial peptide level during acute necrotizing pancreatitis in rats[J]. PLoS One, 2017, 12( 4): e0176583. DOI: 10.1371/journal.pone.0176583.
    [11]
    YU SS, XIONG YY, XU J, et al. Identification of dysfunctional gut microbiota through rectal swab in patients with different severity of acute pancreatitis[J]. Dig Dis Sci, 2020, 65( 11): 3223- 3237. DOI: 10.1007/s10620-020-06061-4.
    [12]
    TAN CC, LING ZX, HUANG Y, et al. Dysbiosis of intestinal microbiota associated with inflammation involved in the progression of acute pancreatitis[J]. Pancreas, 2015, 44( 6): 868- 875. DOI: 10.1097/MPA.0000000000000355.
    [13]
    PAN XH, FANG X, WANG F, et al. Butyrate ameliorates caerulein-induced acute pancreatitis and associated intestinal injury by tissue-specific mechanisms[J]. Br J Pharmacol, 2019, 176( 23): 4446- 4461. DOI: 10.1111/bph.14806.
    [14]
    PAN LL, NIU WY, FANG X, et al. Clostridium butyricum strains suppress experimental acute pancreatitis by maintaining intestinal homeostasis[J]. Mol Nutr Food Res, 2019, 63( 13): e1801419. DOI: 10.1002/mnfr.201801419.
    [15]
    SENDLER M, van den BRANDT C, GLAUBITZ J, et al. NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis[J]. Gastroenterology, 2020, 158( 1): 253- 269.e14. DOI: 10.1053/j.gastro.2019.09.040.
    [16]
    MAREK G, ŚCISKALSKA M, GRZEBIENIAK Z, et al. Decreases in paraoxonase-1 activities promote a pro-inflammatory effect of lipids peroxidation products in non-smoking and smoking patients with acute pancreatitis[J]. Int J Med Sci, 2018, 15( 14): 1619- 1630. DOI: 10.7150/ijms.27647.
    [17]
    HAGAR HH, ALMUBRIK SA, ATTIA NM, et al. Mesna alleviates cerulein-induced acute pancreatitis by inhibiting the inflammatory response and oxidative stress in experimental rats[J]. Dig Dis Sci, 2020, 65( 12): 3583- 3591. DOI: 10.1007/s10620-020-06072-1.
    [18]
    CAO SC, BIAN Y, ZHOU X, et al. A small-molecule activator of mitochondrial aldehyde dehydrogenase 2 reduces the severity of cerulein-induced acute pancreatitis[J]. Biochem Biophys Res Commun, 2020, 522( 2): 518- 524. DOI: 10.1016/j.bbrc.2019.11.128.
    [19]
    SAJADIAN M, HASHEMI M, SALIMI S, et al. The effect of experimental thyroid dysfunction on markers of oxidative stress in rat pancreas[J]. Drug Dev Res, 2016, 77( 4): 199- 205. DOI: 10.1002/ddr.21312.
    [20]
    EL-ASHMAWY NE, KHEDR NF, EL-BAHRAWY HA, et al. Suppression of inducible nitric oxide synthase and tumor necrosis factor-alpha level by lycopene is comparable to methylprednisolone in acute pancreatitis[J]. Dig Liver Dis, 2018, 50( 6): 601- 607. DOI: 10.1016/j.dld.2018.01.131.
    [21]
    MORSY EM EL, AHMED MAE. Carvedilol attenuates l-arginine induced acute pancreatitis in rats through modulation of oxidative stress and inflammatory mediators[J]. Chem Biol Interact, 2020, 327: 109181. DOI: 10.1016/j.cbi.2020.109181.
    [22]
    BUSH N, RANA SS. Ascites in acute pancreatitis: Clinical implications and management[J]. Dig Dis Sci, 2022, 67( 6): 1987- 1993. DOI: 10.1007/s10620-021-07063-6.
    [23]
    TANG YS, KONG J, ZHOU BD, et al. The role of intestinal microbiota in the progression of severe acute pancreatitis and its potential therapeutic implications[J]. Chin J Microecol, 2021, 33( 8): 980- 984. DOI: 10.13381/j.cnki.cjm.202108024.

    唐义爽, 孔婧, 周秉舵, 等. 肠道微生物在重症急性胰腺炎进展中的作用及其潜在的治疗意义[J]. 中国微生态学杂志, 2021, 33( 8): 980- 984. DOI: 10.13381/j.cnki.cjm.202108024.
    [24]
    THOMSON JE, NWEKE EE, BRAND M, et al. Transient expression of interleukin-21 in the second hit of acute pancreatitis may potentiate immune paresis in severe acute pancreatitis[J]. Pancreas, 2019, 48( 1): 107- 112. DOI: 10.1097/MPA.0000000000001207.
    [25]
    GÓMEZ-HURTADO I, SANTACRUZ A, PEIRÓ G, et al. Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis[J]. PLoS One, 2011, 6( 7): e23037. DOI: 10.1371/journal.pone.0023037.
    [26]
    TSUJI Y, WATANABE T, KUDO M, et al. Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis[J]. Immunity, 2012, 37( 2): 326- 338. DOI: 10.1016/j.immuni.2012.05.024.
    [27]
    RÍOS-COVIÁN D, RUAS-MADIEDO P, MARGOLLES A, et al. Intestinal short chain fatty acids and their link with diet and human health[J]. Front Microbiol, 2016, 7: 185. DOI: 10.3389/fmicb.2016.00185.
    [28]
    BACH KNUDSEN KE, LÆRKE HN, HEDEMANN MS, et al. Impact of diet-modulated butyrate production on intestinal barrier function and inflammation[J]. Nutrients, 2018, 10( 10): 1499. DOI: 10.3390/nu10101499.
    [29]
    TIAN L, ZHOU XQ, JIANG WD, et al. Sodium butyrate improved intestinal immune function associated with NF-κB and p38MAPK signalling pathways in young grass carp(Ctenopharyngodon idella)[J]. Fish Shellfish Immunol, 2017, 66: 548- 563. DOI: 10.1016/j.fsi.2017.05.049.
    [30]
    WANG CC, WU H, LIN FH, et al. Sodium butyrate enhances intestinal integrity, inhibits mast cell activation, inflammatory mediator production and JNK signaling pathway in weaned pigs[J]. Innate Immun, 2018, 24( 1): 40- 46. DOI: 10.1177/1753425917741970.
    [31]
    DAS NK, SCHWARTZ AJ, BARTHEL G, et al. Microbial metabolite signaling is required for systemic iron homeostasis[J]. Cell Metab, 2020, 31( 1): 115- 130.e6. DOI: 10.1016/j.cmet.2019.10.005.
    [32]
    van den BERG FF, van DALEN D, HYOJU SK, et al. Western-type diet influences mortality from necrotising pancreatitis and demonstrates a central role for butyrate[J]. Gut, 2021, 70( 5): 915- 927. DOI: 10.1136/gutjnl-2019-320430.
    [33]
    BÄCKHED F, NORMARK S, SCHWEDA EKH, et al. Structural requirements for TLR4-mediated LPS signalling: A biological role for LPS modifications[J]. Microbes Infect, 2003, 5( 12): 1057- 1063. DOI: 10.1016/s1286-4579(03)00207-7.
    [34]
    YE SJ, SI CL, DENG J, et al. Understanding the effects of metabolites on the gut microbiome and severe acute pancreatitis[J]. Biomed Res Int, 2021, 2021: 1516855. DOI: 10.1155/2021/1516855.
    [35]
    LI XY, HE C, LI NS, et al. The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice[J]. Gut Microbes, 2020, 11( 6): 1774- 1789. DOI: 10.1080/19490976.2020.1770042.
    [36]
    GONG L, SONG X, SU L, et al. Research progress of intestinal microecology in acute pancreatitis[J]. Chin J Clin Nutr, 2021, 29( 5): 308- 314. DOI: 10.3760/cma.j.cn115822-20210901-00171.

    龚亮, 宋晓, 苏磊, 等. 急性胰腺炎肠道微生态的研究进展[J]. 中华临床营养杂志, 2021, 29( 5): 308- 314. DOI: 10.3760/cma.j.cn115822-20210901-00171.
    [37]
    ZHANG T, GAO GQ, SAKANDAR HA, et al. Gut dysbiosis in pancreatic diseases: A causative factor and a novel therapeutic target[J]. Front Nutr, 2022, 9: 814269. DOI: 10.3389/fnut.2022.814269.
    [38]
    HANG H, LIU X. Current application status of probiotics in the treatment of acute pancreatitis[J]. Clin J Med Offic, 2021, 49( 4): 374- 375, 379. DOI: 10.16680/j.1671-3826.2021.04.05.

    韩浩, 刘旭. 益生菌在急性胰腺炎治疗中应用现状[J]. 临床军医杂志, 2021, 49( 4): 374- 375, 379. DOI: 10.16680/j.1671-3826.2021.04.05.
    [39]
    LUO YY, LIU X. Research progress of probiotics in adjuvant treatment of severe acute pancreatitis[J]. Trauma Crit Care Med, 2021, 9( 2): 161- 164. DOI: 10.16048/j.issn.2095-5561.2021.02.22.

    罗娅媛, 刘旭. 益生菌辅助治疗重症急性胰腺炎研究进展[J]. 创伤与急危重病医学, 2021, 9( 2): 161- 164. DOI: 10.16048/j.issn.2095-5561.2021.02.22.
    [40]
    OLÁH A, BELÁGYI T, ISSEKUTZ A, et al. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis[J]. Br J Surg, 2002, 89( 9): 1103- 1107. DOI: 10.1046/j.1365-2168.2002.02189.x.
    [41]
    PAN LL, LI BB, PAN XH, et al. Gut microbiota in pancreatic diseases: Possible new therapeutic strategies[J]. Acta Pharmacol Sin, 2021, 42( 7): 1027- 1039. DOI: 10.1038/s41401-020-00532-0.
    [42]
    BESSELINK MG, van SANTVOORT HC, BUSKENS E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial[J]. Lancet, 2008, 371( 9613): 651- 659. DOI: 10.1016/S0140-6736(08)60207-X.
    [43]
    van BAAL MC, KOHOUT P, BESSELINK MG, et al. Probiotic treatment with Probioflora in patients with predicted severe acute pancreatitis without organ failure[J]. Pancreatology, 2012, 12( 5): 458- 462. DOI: 10.1016/j.pan.2012.08.004.
    [44]
    BONGAERTS GPA, SEVERIJNEN RSVM. A reassessment of the PROPATRIA study and its implications for probiotic therapy[J]. Nat Biotechnol, 2016, 34( 1): 55- 63. DOI: 10.1038/nbt.3436.
    [45]
    KECSKÉS G, BELÁGYI T, OLÁH A. Early jejunal nutrition with combined pre- and probiotics in acute pancreatitis: Prospective, randomized, double-blind investigations[J]. Magy Seb, 2003, 56( 1): 3- 8.
    [46]
    BESSELINK MGH, TIMMERMAN HM, BUSKENS E, et al. Probiotic prophylaxis in patients with predicted severe acute pancreatitis(PROPATRIA): Design and rationale of a double-blind, placebo-controlled randomised multicenter trial[ISRCTN38327949][J]. BMC Surg, 2004, 4: 12. DOI: 10.1186/1471-2482-4-12.
    [47]
    KARAKAN T, ERGUN M, DOGAN I, et al. Comparison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: A prospective randomized double-blind study[J]. World J Gastroenterol, 2007, 13( 19): 2733- 2737. DOI: 10.3748/wjg.v13.i19.2733.
    [48]
    OLÁH A, BELÁGYI T, PÓTÓ L, et al. Synbiotic control of inflammation and infection in severe acute pancreatitis: A prospective, randomized, double blind study[J]. Hepato-gastroenterology, 2007, 54( 74): 590- 594.
    [49]
    QIN HL, ZHENG JJ, TONG DN, et al. Effect of Lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis[J]. Eur J Clin Nutr, 2008, 62( 7): 923- 930. DOI: 10.1038/sj.ejcn.1602792.
    [50]
    BESSELINK MG, van SANTVOORT HC, RENOOIJ W, et al. Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis[J]. Ann Surg, 2009, 250( 5): 712- 719. DOI: 10.1097/SLA.0b013e3181bce5bd.
    [51]
    LATA J, JURÁNKOVÁ J, STIBŮREK O, et al. Probiotics in acute pancreatitis: A randomised, placebo-controlled, double-blind study[J]. Vnitr Lek, 2010, 56( 2): 111- 114.
    [52]
    SHARMA B, SRIVASTAVA S, SINGH N, et al. Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: A double-blind randomized controlled trial[J]. J Clin Gastroenterol, 2011, 45( 5): 442- 448. DOI: 10.1097/MCG.0b013e318201f9e2.
    [53]
    CUI LH, WANG XH, PENG LH, et al. The effects of early enteral nutrition with addition of probiotics on the prognosis of patients suffering from severe acute pancreatitis[J]. Chin Critical Care Med, 2013, 25( 4): 224- 228. DOI: 10.3760/cma.j.issn.2095-4352.2013.04.011.

    崔立红, 王晓辉, 彭丽华, 等. 早期肠内营养加微生态制剂对重症急性胰腺炎患者疗效的影响[J]. 中华危重病急救医学, 2013( 4): 224- 228. DOI: 10.3760/cma.j.issn.2095-4352.2013.04.011.
    [54]
    ZHU YM. Effects of probiotics in treatment of severe acute pancreatitis[J]. World Chin J Dig, 2014, 22( 32): 5013. DOI: 10.11569/wcjd.v22.i32.5013.
    [55]
    WU P, YU Y, LI L, et al. Effect and safety of probiotics combined early enteral nutrition on severe acute pancreatitis patients[J]. Biomed Res Tokyo, 2017, 28: 1403- 1407.
    [56]
    WAN YD, ZHU RX, BIAN ZZ, et al. Effect of probiotics on length of hospitalization in mild acute pancreatitis: A randomized, double-blind, placebo-controlled trial[J]. World J Gastroenterol, 2021, 27( 2): 224- 232. DOI: 10.3748/wjg.v27.i2.224.
    [57]
    ROHITH G, SURESHKUMAR S, ANANDHI A, et al. Effect of synbiotics in reducing the systemic inflammatory response and septic complications in moderately severe and severe acute pancreatitis: A prospective parallel-arm double-blind randomized trial[J]. Dig Dis Sci, 2023, 68( 3): 969- 977. DOI: 10.1007/s10620-022-07618-1.
    [58]
    WANG JY, JIANG ML, HU Y, et al. Lactulose regulates gut microbiota dysbiosis and promotes short-chain fatty acids production in acute pancreatitis patients with intestinal dysfunction[J]. Biomed Pharmacother, 2023, 163: 114769. DOI: 10.1016/j.biopha.2023.114769.
    [59]
    LI M, LIANG P, LI ZZ, et al. Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis[J]. Front Microbiol, 2015, 6: 692. DOI: 10.3389/fmicb.2015.00692.
    [60]
    DEFILIPP Z, BLOOM PP, TORRES SOTO M, et al. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant[J]. N Engl J Med, 2019, 381( 21): 2043- 2050. DOI: 10.1056/nejmoa1910437.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (193) PDF downloads(38) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return